Intranasal Chitosan Nano-Formulations: A Novel Frontier in Brain Cancer Therapy

发布时间:2026-11-02 | 来源:MDPI Polymers | 作者:Sina M. Matalqah, Zainab M. Lafi, Randa Atwan, Sara Yousef Asha, Asem N. Mhaidat

Direct nose-to-brain drug delivery is emerging as a promising approach in neuro-oncology because it offers a non-invasive, needle-free route for delivering ther

Direct nose-to-brain drug delivery is emerging as a promising approach in neuro-oncology because it offers a non-invasive, needle-free route for delivering therapeutics to the brain while partially bypassing the blood–brain barrier (BBB). This approach takes advantage of the natural connections between the nasal cavity and the central nervous system, allowing drugs administered through the nose to reach brain tissues through the olfactory and trigeminal pathways. Despite its potential, successful clinical translation remains challenging because the nasal cavity presents several physiological barriers. Mucus can trap drug molecules, mucociliary clearance can rapidly remove them, and nasal enzymes can degrade them before they reach their target. Advanced nanocarrier systems are therefore being developed to overcome these barriers and improve drug transport through intracellular, paracellular, and transcellular pathways. In this context, specific structural modifications can enhance drug retention, mucus penetration, cellular uptake, and targeting efficiency. Important strategies include the use of mucoadhesive materials such as chitosan to increase residence time in the nasal cavity; hydrophilic coatings such as polyethylene glycol (PEG) to improve movement through mucus; targeting ligands to promote selective cellular uptake; and stimuli-responsive systems that respond to local conditions such as pH, redox state, or glutathione (GSH) levels. These advances are particularly relevant to the treatment of glioblastoma multiforme (GBM), one of the most aggressive and difficult-to-treat brain tumors. GBM is characterized by extensive infiltration into surrounding healthy brain tissue, making it difficult to achieve effective drug concentrations throughout both the main tumor mass and its invasive margins. Intranasally delivered chitosan-based nano-formulations may help address this problem through a series of transport steps. After administration, the nanoparticles can int…

返回资讯频道